A Part of the University of Maryland Medical Center

Connect with UMGCC
Facebook Twitter YouTube Blog iPhone
Email PageEmail page Print PagePrint page

Hematologic Malignancies

Diagnostic and Treatment Services

 

Ask the Expert

Dr. Baer’s Bio Image

Get answers to your Myelodysplastic Syndromes questions.

Dr. Baer’s Bio | Q&A Archive

Note: This is for informational purposes only. Doctors cannot provide a diagnosis or individual treatment advice via e-mail. Please consult your physician about your specific health care concerns.

Related Content


 

Patients with hematologic malignancies often have a complex array of medical issues. Our Program for Hematologic Malignancies brings together a team of specialists to provide patients with individualized treatment plans without duplicating services. Patients are evaluated by:

The Program for Hematologic Malignancies offers a comprehensive range of diagnostic and treatment services designed to provide patients with the most effective care possible. Services include:

We also treat benign hematology – bleeding disorders, red cell disorders, platelet abnormalities and white cell disorders.

A major goal of Hematologic Malignancies Program is to develop new curative approaches for leukemias, lymphomas and myelomas. For example:

  1. We offer a number of NCI-funded Phase I and II innovative clinical trials of new drugs and novel drug combinations for patients with newly diagnosed or relapsed and/or refractory leukemias and myelodysplasia.
  2. We use novel immunotherapy approaches to treat Chronic Myelogenous Leukemia (CML), lymphoma and multiple myeloma.
  3. We offer new molecularly-targeted drugs for multiple myeloma.

If you would like to make an appointment, or if you are a physician with a patient who would benefit from the expertise and treatment we offer, please call us at 1-800-888-8823


This page was last updated on: May 19, 2009.


For More Information